Provider Alert! Change in Preferred Drug List Status for the Bronchodilators, Beta Agonist
Date: November 3, 2023 Attention: All Providers Effective Date: October 31, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective October 31, 2023, the Texas Health and Human Services Commission (HHSC) removed non-preferred status from generic levalbuterol inhalation solution on the preferred drug list. This is in response to the manufacturer shut down, therefore the discontinuation of the product. The preferred status of the brand name Xopenex inhalation solution (NDCs: 17478-0172-24, 17478-0173-24, 17478-0174-24) will not change...
